Bihua Chen - Jun 22, 2022 Form 4 Insider Report for Biomea Fusion, Inc. (BMEA)

Role: Director, 10%+ Owner
Signature: /s/ CORMORANT ASSET MANAGEMENT, LP By: Cormorant Asset Management GP, LLC, its General Partner, By: Bihua Chen, Managing Member
Stock symbol: BMEA
Transactions as of: Jun 22, 2022
Transactions value $: $0
Form type: 4
Date filed: 6/24/2022, 04:00 PM
Previous filing: Apr 7, 2022
Next filing: Dec 21, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	BMEA	Common Stock						3.17M	Jun 22, 2022	See Footnotes	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BMEA	Stock Option (right to buy)	Award	$0	+23.9K		$0.00	23.9K	Jun 22, 2022	Common Stock	23.9K	$10.20	Direct	F4, F5
holding	BMEA	Stock Option (right to buy)						28.9K	Jun 22, 2022	Common Stock	28.9K	$17.00	Direct	F3, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares reported herein are held by Cormorant Global Healthcare Master Fund, LP (the "Master Fund"), Cormorant Private Healthcare Fund III, LP (the "Fund III"), and a managed account (the "Account"). Cormorant Asset Management, LP ("Cormorant") serves as the investment manager of the Master Fund, Fund III, and the Account. Bihua Chen serves as manager of the general partner of Cormorant. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose.
F2	Represents (i) 1,395,928 shares of Common Stock held by the Master Fund, (ii) 1,717,232 shares of Common Stock held by Fund III, and (iii) 57,712 shares of Common Stock held by the Account.
F3	The options were granted with a 36 month vesting period, vesting monthly.
F4	Stock options granted to Bihua Chen, in her capacity as a director of the Issuer.
F5	The options vest in full upon the earlier of (i) the one-year anniversary of the date of grant or (ii) immediately prior to the annual meeting of the Issuer's stockholders that occurs following the date of grant.